Insights & Analysis

There’s one constant in healthcare: change. Count on us to break down the trends so you can stay up to date. Follow our take on each piece of this deep, intertwined, and often perplexing industry to find opportunities and practical approaches to move healthcare forward.

More Variable Molecular Diagnostic Rates Likely

As molecular diagnostics become more common in treating certain diseases - especially cancer - their reimbursement will be an important part of value messaging for many drug therapies.

Avalere Spotlight: Life Sciences in 2014

The 2014 market will be characterized by challenge and transformation across payers, providers, and patients which will create pressures for the pharmaceutical and medical device industries to:

Evaluating the Usability of CER for Patient and Provider Decision Making

Comparative effectiveness research (CER) has the potential to inform many decisions. While a common threshold for determining whether a CER finding should be disseminated to the public is its methodological quality, a study with high methodological quality is not necessarily one that patients and providers will find usable for their decision making.

The Joint Commission and AMA Identify Five Medical Treatments that May Be Overused

The Joint Commission and the American Medical Association (AMA) Convened Physician Consortium for Performance Improvement® released a report on July 8, which was previously under an embargo, focusing on the overuse of tests, treatments, or procedures that provide zero to negligible benefit and expose patients to risk of harm.

Exchange Operational Models for 2014

In 2014, most states are relying on the federal government for some or all exchange operational functions.

Sign up to receive more insights about
Please enter your email address to be notified when new insights are published.

Back To Top